Article Details

Second-Generation CAR T-Cell Therapy Is 'Highly Promising' in Relapsed/Refractory B-NHL

Retrieved on: 2021-06-08 18:42:31

Tags for this article:

Click the tags to see associated articles and topics

Second-Generation CAR T-Cell Therapy Is 'Highly Promising' in Relapsed/Refractory B-NHL. View article details on hiswai:

Excerpt

... led to improved response rates – as well as a favorable safety profile – in patients with relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL), ...

Article found on: www.oncnursingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up